Table 4.
Factors for timely completiona of vaccines among infants whose caregivers were interviewed (N = 465)
| Caregiver characteristics | Timely completion, n (%) | Delayed completion, n (%) | OR (P value) |
|---|---|---|---|
| Overall | 282 (60.7) | 183 (39.4) | |
| Sex | |||
| Female | 274 (97.2) | 181 (98.9) | – |
| Male | 8 (2.8) | 2 (1.1) | 2.6 (0.2) |
| Relationship to infant | |||
| Parent | 245 (86.9) | 165 (90.2) | – |
| Others | 37 (13.1) | 18 (9.8) | 1.4 (0.3) |
| Age group | |||
| 18–24 years | 93 (33.0) | 66 (36.1) | – |
| 25–34 years | 127 (45.0) | 89 (48.6) | 1.0 (1.0) |
| 35 years and above | 62 (22.0) | 28 (15.3) | 1.6 (0.1) |
| No. of children of female caregivers | |||
| 0–2 children | 185 (65.6) | 106 (57.9) | – |
| 3–4 children | 71 (25.2) | 51 (27.9) | 0.8 (0.3) |
| 5 or more children | 26 (9.2) | 26 (14.2) | 0.6 (0.07) |
| Level of education | |||
| Attended primary school/never attended school | 119 (42.2) | 65 (35.5) | – |
| Attended secondary school | 145 (51.4) | 101 (55.2) | 1.4 (0.4) |
| Attended post-secondary school | 18 (6.4) | 17 (9.3) | 1.7 (0.1) |
BCG Bacillus Calmette-Guérin, HepB Hepatitis B vaccine, IPV inactivated poliovirus vaccine, OPV oral poliovirus vaccine, OR odds ratio, Penta pentavalent vaccine, PCV13 pneumococcal conjugate vaccine (13-valent)
aTimely completion of vaccines is defined as 3 doses of Penta, PCV13, and OPV, and one dose each of BCG birth dose, HepB birth dose, and IPV received within 6 months of age